Nortem (Temazepam)

Temazepam binds to the benzodiazepine site on the GABA‑A receptor, increasing the frequency of chloride channel opening when GABA is present. This amplifies inhibitory neurotransmission, producing a calming effect that reduces sleep latency and supports continuous sleep.

The dose of temazepam is individualized by the prescribing clinician based on the patient’s age, severity of insomnia, and overall health. Typical adult regimens range from low to moderate strengths, but the exact amount and frequency must be determined by a qualified healthcare professional.

Limited data exist on the safety of temazepam in pregnancy and lactation. Because benzodiazepines may cross the placenta and appear in breast milk, they are generally avoided unless the potential benefit justifies the risk. Consultation with a obstetric or pediatric specialist is essential.

To request Nortem, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nortem (temazepam) is a benzodiazepine, whereas alternatives such as zolpidem belong to the non‑benzodiazepine “Z‑drug” class. Benzodiazepines tend to have a broader sedative profile and a higher potential for dependence, while Z‑drugs often have a shorter half‑life and may cause fewer next‑day effects. Choice depends on clinical judgment, patient history and risk assessment.

Nortem should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, heat and direct sunlight, and keep them out of reach of children.

Nortem is taken orally, usually with a glass of water. It may be taken with or without food, but patients should follow the prescribing clinician’s instructions regarding timing relative to meals to ensure consistent absorption.

The most serious risks include the development of physical dependence, withdrawal symptoms upon abrupt discontinuation, respiratory depression especially when combined with other CNS depressants, and rare severe allergic reactions. Patients should be monitored closely for signs of misuse or adverse reactions.

Nortem is contraindicated in individuals with known hypersensitivity to temazepam or other benzodiazepines, severe respiratory insufficiency, acute narrow‑angle glaucoma, and in patients with a history of severe substance use disorder. Caution is also advised for the elderly, pregnant or nursing women, and those taking interacting CNS depressants.